Your browser doesn't support javascript.
loading
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
Taguchi, Isao; Iimuro, Satoshi; Iwata, Hiroshi; Takashima, Hiroaki; Abe, Mitsuru; Amiya, Eisuke; Ogawa, Takanori; Ozaki, Yukio; Sakuma, Ichiro; Nakagawa, Yoshihisa; Hibi, Kiyoshi; Hiro, Takafumi; Fukumoto, Yoshihiro; Hokimoto, Seiji; Miyauchi, Katsumi; Yamazaki, Tsutomu; Ito, Hiroshi; Otsuji, Yutaka; Kimura, Kazuo; Takahashi, Jun; Hirayama, Atsushi; Yokoi, Hiroyoshi; Kitagawa, Kazuo; Urabe, Takao; Okada, Yasushi; Terayama, Yasuo; Toyoda, Kazunori; Nagao, Takehiko; Matsumoto, Masayasu; Ohashi, Yasuo; Kaneko, Tetsuji; Fujita, Retsu; Ohtsu, Hiroshi; Ogawa, Hisao; Daida, Hiroyuki; Shimokawa, Hiroaki; Saito, Yasushi; Kimura, Takeshi; Inoue, Teruo; Matsuzaki, Masunori; Nagai, Ryozo.
Afiliación
  • Taguchi I; Department of Cardiology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan (I.T.).
  • Iimuro S; Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (S.I., T. Kaneko).
  • Iwata H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan (H.I., K.M., H.D.).
  • Takashima H; Department of Cardiology, Aichi Medical University, Nagakute, Japan (H.T.).
  • Abe M; Department of Cardiology, National Hospital Organization Kyoto Medical Center, Japan (M.A.).
  • Amiya E; Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan (E.A.).
  • Ogawa T; Department of Cardiovascular Medicine, Hokuto Social Medical Corp, Hokuto Hospital, Obihiro, Japan (T.O.).
  • Ozaki Y; Department of Cardiology, Fujita Health University School of Medicine, Toyoake, Japan (Y. Ozaki).
  • Sakuma I; Caress Sapporo Hokko Memorial Clinic, Sapporo, Japan (I.S.).
  • Nakagawa Y; Department of Cardiology, Tenri Hospital, Japan (Y.N.).
  • Hibi K; Division of Cardiology, Yokohama City University Medical Center, Japan (K.H., K. Kimura).
  • Hiro T; Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan (T.H., A.H.).
  • Fukumoto Y; Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Japan (Y.F.).
  • Hokimoto S; Department of Cardiovascular Medicine, Kumamoto University Hospital, Japan (S.H.).
  • Miyauchi K; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan (H.I., K.M., H.D.).
  • Yamazaki T; Clinical Research Support Center, University of Tokyo Hospital, Japan (T.Y.).
  • Ito H; Department of Cardiovascular Medicine, Okayama University, Graduate School of Medicine, Japan (H.I.).
  • Otsuji Y; Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kita-Kyushu, Japan (Y. Otsuji).
  • Kimura K; Division of Cardiology, Yokohama City University Medical Center, Japan (K.H., K. Kimura).
  • Takahashi J; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (J.T., H.S.).
  • Hirayama A; Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan (T.H., A.H.).
  • Yokoi H; Cardiovascular Center, Fukuoka Sanno Hospital, Japan (H.Y.).
  • Kitagawa K; Department of Neurology, Tokyo Women's Medical University, Japan (K. Kitagawa).
  • Urabe T; Department of Neurology, Juntendo University Urayasu Hospital, Japan (T.U.).
  • Okada Y; Clinical Research Institute and Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan (Y.O.).
  • Terayama Y; Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan (Y.T.).
  • Toyoda K; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan (K.T.).
  • Nagao T; Department of Neurology, Nippon Medical School Tama-Nagayama Hospital, Tama, Japan (T.N.).
  • Matsumoto M; Japan Community Healthcare Organization, Hoshigaoka Medical Center, Hirakata, Japan (M. Matsumoto).
  • Ohashi Y; Department of Integrated Science and Technology for Sustainable Society, Chuo University, Tokyo, Japan (Y. Ohashi).
  • Kaneko T; Teikyo Academic Research Center, Teikyo University, Tokyo, Japan (S.I., T. Kaneko).
  • Fujita R; Department of Clinical Research Medicine, School of Medicine, Teikyo University, Tokyo, Japan (R.F.).
  • Ohtsu H; National Center for Global Health and Medicine, Center for Clinical Sciences, Tokyo, Japan (H. Ohtsu).
  • Ogawa H; National Cerebral and Cardiovascular Center, Suita, Japan (H. Ogawa).
  • Daida H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan (H.I., K.M., H.D.).
  • Shimokawa H; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (J.T., H.S.).
  • Saito Y; Chiba University, Japan (Y.S.).
  • Kimura T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan (T. Kimura). taketaka@kuhp.kyoto-u.ac.jp inouet@dokkyomed.ac.jp.
  • Inoue T; Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan (T.I.). taketaka@kuhp.kyoto-u.ac.jp inouet@dokkyomed.ac.jp.
  • Matsuzaki M; St. Hill Hospital, Ube, Japan (M. Matsuzaki).
  • Nagai R; Jichi Medical University, Shimotsuke, Japan (R.N.).
Circulation ; 137(19): 1997-2009, 2018 05 08.
Article en En | MEDLINE | ID: mdl-29735587
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quinolinas / Enfermedad de la Arteria Coronaria / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Dislipidemias / LDL-Colesterol Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Circulation Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Quinolinas / Enfermedad de la Arteria Coronaria / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Dislipidemias / LDL-Colesterol Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Circulation Año: 2018 Tipo del documento: Article